03:37 PM EST - Isotechnika Pharma Inc. : announced the signing of a three-year Non-Clinical Evaluation Agreement with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health. Pursuant to the agreement, NIAID-funded contractors will evaluate the Company's portfolio of non-immunosuppressive cyclosporine analogue molecules as anti-viral agents. Isotechnika Pharma Inc.
shares T.ISA are trading up $0.01 at $0.12.
